Title:
免疫療法のためのRNA製剤
Document Type and Number:
Japanese Patent JP6832904
Kind Code:
B2
Abstract:
The present invention is in the field of immunotherapy, in particular tumor immunotherapy. The present invention provides pharmaceutical formulations for delivering RNA to antigen presenting cells such as dendrite cells (DCs) in the spleen after systemic administration. In particular, the formulations described herein enable to induce an immune response after systemic administration of antigen-coding RNA.
More Like This:
Inventors:
Ughur Shaheen
Heinrich Haas
Sebastian writer
Mustafa Dicken
Daniel Fritz
Martin Menk
Lena Malaine Kranz
Kerstin Reuter
Heinrich Haas
Sebastian writer
Mustafa Dicken
Daniel Fritz
Martin Menk
Lena Malaine Kranz
Kerstin Reuter
Application Number:
JP2018222175A
Publication Date:
February 24, 2021
Filing Date:
November 28, 2018
Export Citation:
Assignee:
TRON-Translationare on Corogee an der Universitate Smedizin der Johannes Gutenberg-Universitate Mainz Gemainn Nutsige Geembehr
Bayon Tech Ale Ner Pharmaceuticals Game Behr
Bayon Tech Ale Ner Pharmaceuticals Game Behr
International Classes:
A61K31/7105; A61K9/127; A61K39/00; A61K47/18; A61K47/24; A61K47/28; A61K47/44; A61K48/00; A61P35/00; A61P37/04
Domestic Patent References:
JP2010059064A | ||||
JP2015514076A |
Foreign References:
WO2011005799A1 |
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe